- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Pharma Unplugged: Episode# 2- Layoffs & Bonuses
Reid Paul, Editor-in-Chief of Pharmaceutical Representative Magazine joins host George Koroneos to discuss the top five pharmaceutical industry news stories of the week
Layoffs & Bonuses
Pharma Unplugged Podcast Series
Recorded: 12/3/2009
Air Date: 12/7/2009
Host: George Koroneos, Pharm Exec
Cohost: Reid Paul, Pharm Rep Magazine
Download Adobe Flash Player
This week we discuss:
- Pfizer’s medical education relationship with the Canadian Medical Association
- Journalists take FDA to task for not being transparent enough
- Layoffs and job cuts at Sanofi-Aventis
- New report shows that DTC receives more funding than sales calls in certain drug categories
- CEO compensation bump in life science
Sponsors
Patient Segmentation Strategies
WEBCAST – Sponsor (Medpoint)
How Virtual Media Can Save the Medical Speaker Program
WEBCAST – Sponsor (Healthgrades)
Driving Medication Compliance
PODCAST – Sponsor (AdherenceRx)
Episode# 1
A Link Apart : FDA Social Media Hearing
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
